Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience;Valore prognostico e curativo del linfonodo sentinella nel trattamento chirurgico del cancro della mammella. Analisi di 377 pazienti

Annali Italiani di Chirurgia

Volumn 81, Issue 2, 2010, Pages 103-113

  Iannace, Carlo ^a   Di Libero, Lorenzo ^a   Lepore, Maria ^b   De Stefano, Noè ^b   Buono, Marcella ^b   Sciascia, Valerio ^a   Manetta, Fiorenza ^a   Giordano, Marco ^a   Scetta, Giovanni ^a   Varriale, Roberto ^a   Esposito, Daniela ^a   Tartaglia, Ernesto ^a   Ferbo, Umberto ^b   Miletto, Paolo ^b   Caracciolo, Francesco ^a  

^a Azienda Ospedaliera San Giuseppe Moscati   (Italy)

^b Azienda Ospedaliera San Giuseppe Moscati Avellino   (Italy)

Author keywords

Axillary dissection; Axillary lymphnodes recurrence; Sentinel node dissection

Indexed keywords

ADULT; AGED; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 77956992190     PISSN: 2239253X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. International Union Against Cancer (UICC): TNM classification of malignant tumours. 6th ed. New York:Wiley-Liss, 2002.
2. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Barman CM, Molin MR, Yurko JE, Perry RR, William R: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulphur colloid and isosulfan blue dye. Ann Surg, 2001; 233:51-9.
3. Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, Zurrida S, Veronesi P, Intra M, Gennari R, Vento R, Luini A, Tullii M, Bassani G, Rotmensz N: Sentinel node biopsy in breast cancer: Early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer, 2005; 41:231-7.
4. Albertini JJ, Lyman GH, Cox C, et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA, 1996; 11:1818-822.
5. McMasters KM, Tuttle TM, Carlson DJ, et al: Sentinel node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol, 2000; 18:2560-566.
6. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival: A Bayesian meta-analysis. Ann Surg Oncol, 1999; 6(1):109-16.
7. Giuliano A, Schwartz G: Summary of the proceedings of the Philadelphia Consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. Semin Breast Dis, 2002; 5:2542-551.
8. Giuliano A, Haigh PI, Brennan MB, et al: Prospective observational study of sentinel lymphadenectomywithout furter axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol, 2000; 18:2553.
9. Alkhatib W, Condor C, Fang F: Solitary positive sentinel lymph node accompained by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection. Am J Surg, 2007; 194:856-59.
10. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinrl node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 2003; 349:546-53.
11. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah T, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ: Randomized multicenter trial of sentinel node biopsy versus axillary treatment in operable breast cancer: the ALMANAC trial. J Nat Cancer Inst, 2006; 98:599-609.
12. Turner RR, Ollila DW, Krasne DL, Giuliano AE: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg, 1997; 226:271-78.
13. Yap KP, McCready DR, Narod S, et al: Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma. Cancer, 2003; 97:1369-375.
14. Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE: Long- Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer. Ann Surg Oncol, 2008; 15(7):1996-2005.
15. Groetelaers RPTGC, van Belo CLH, Nijhuis PHA, Schapers RFM, Gerritsen HAM: Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: A followup study after 5 years. EJSO, 2009; 35:159-63.
16. Fortunato L, Drago S, Vitelli CE, Santoni M, Gucciardo G, Cabassi A, Farina M, La Pinta M, Remedi M, Pagano G, Silipo T, Terribile D, Stagnitto D, Grassi GB: Il linfonodo sentinella nel cancro della mammella. Esperienza del Rome Breast Cancer Study Group. Chir Ital, 2006; 58(6):689-96.
17. Veronesi U, Paganelli G, Viale G et al: Sentinel Lymph node biopsy as staging procedure in breast cancer: Update of a randomized controller study. Lancet Oncol, 2006; 7:983-990.
18. Classe JM, Curtet C, Campion L et al: Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol, 2003; 29:426-433.
19. Krag DN, Anderson SJ, Julian TB, et al: Technical outcomes of sentinel lymph node resection and conventional axillary lymph node dissection in patients with clinically node negative breast cancer: Results from the NSABP B-32 randomized phase III trial. Lancet, 2007; 8:881-8.
20. Tousimis E, Van Zee KJ, Fey JV, Hoque LW, Tan LK, Cody HS 3rd, Borgen PI, Montgomery LL: The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancer. J Am Coll Surg, 2003; 197:529-35.
21. Kumar R, Jana S, Heiba S, et al: Retrospective analysis of sentinel node localization in multifocal, multicentric palpable or nonpalpable breast cancer. J Nucl Med, 2003; 44:7-10.
22. Harlow SP, Krag DN: Sentinel lymph node:why study it? Implications of the B-32 study. Semin Surg Oncol, 2001; 20:224-29.
23. Poletti P, Fenaroli P, Milesi A, Paludetti A, Mangiarotti S, Virotta G, Candiago E, Bettini A, Caremoli ER, Labianca R, Todini C: Axillary recurrence in sentinel lymph node-negative breast cancer patients. Annals of Oncology, 2008; 19:1842-846.
24. Veronesi U, Orecchia R, Luini A, et al: Full dose intraoperative radiotherapy with electrons during breast conserving surgery. Experience with 590 cases. Ann Surg, 2005; 242(1):101-106.
25. Bergkvist L, de Boniface J, Jönsson PE et al: Axillary recurrence rate after negative sentinel node biopsy in breast cancer. Ann Surg, 2008; 247:150-56.
26. Giuliano AE: Mapping a pathway for axillary staging: A person- al perspective on the current status of sentinel lymph node dissection for breast cancer. Arch Surg, 1999; 34:195-99.
27. Tuttle TM, Colbert M: Subareolar injection of 99Tc facilitates sentinel lymph node identification. Ann Surg Oncol, 2002; 9:77-81.
28. Memorial Sloan Kettering SLN: Normogram. Available at: www.mskcc.org/mskcc/html/15938.cfm.
29. Smidt ML, Kuster DM, Van der Wilt Jan, et al: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in The Netherlands? Ann Surg Oncol, 2005; 12:1066-72.
30. Goyal A, Douglas-Jones A, Newcombe RG, et al: ALMANACA Trilist Group. Predictors of non-sentinel node metastasis in breast cancer patients. Eur J Cancer, 2004; 40:1731-737.
31. Sony NK, Carmalt HL, Gillett DJ, et al: Evaluation of breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol, 2005; 31:958-64.
32. Stitzenberg KB, Meyer AA, Stern SL, et al: Extracapsular extension of the sentinel lymph node metastasis: A predictor of nonsentinel node tumor burden. Ann Surg, 2003; 237:607-13.
33. Ballarin A, Franchini Z, D'Atri C, Marchi R, Tedeschi U: Lo studio del linfonodo sentinella nel cancro della mammella. Analisi di 235 casi e revisione della letteratura. Chir Ital, 2006; 58,(5):583-95.
34. Bauer TW, Spitz FR, Callans LS, Alavi A, Mick R, Weinstein SP, Bedrosian I, Fraker DL, Bauer TL, Czerniecki BJ: Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol, 2002; 9:169-76.
35. Fernandez K: Is sentinel lymphadenectomy accurate in multifocal and multicentric breast cancer? Ann Surg Oncol, 2002; 9:S16-S17.
36. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia m, Petrek JA, Cody HS, Van Zee KJ: Sentinel lymph node biopsy: is it indicated in patient with high-risk ductal carcinoma-in situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol, 2000; 7:636-42.
37. Zunzunegui RG, Chung MA, Oruwari J, Golding D, Marchant DJ, Cady B: Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease? Arch Surg, 2003; 138:537-40.
38. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Kenney GL, Lawton TJ, Czerniecki BJ: Sentinel lymph node with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol, 1999; 17:1720-6.
39. Giard S, Baranzelli MC, Robert D, Chauvet MP, Robin YM, Cabaret V, Carpentier P, Dugrain MP, Fournier Ch: Surgical implication of sentinel node with micrometastasis disease in invasive breast cancer. Eur J Surg Oncol, 2004; 30:924-29.
40. Cserni G: A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol, 2004; 57:467-71.
41. Zavagno G, De Salvo GL, Bozza F, Scalco G, Marconato R, Valletta S, Racano C, Burelli P, Nitti D, Lise M: Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res Treat, 2004; 86:171-79.
42. Carcoforo P, Bergossi L, Basaglia E, Soliani G, Querzoli P, Zambrini E, Pozza E, Feggi L: Prognostic and therapeutic impact of sentinel node metastasis in patients with invasive breast cancer. Tumori, 2002; 88:S4-S5.
43. den Bakker MA, van Weeszenberg A, de Kanter AY, Beverdam FH, Pritchard C, van der Kwast TH, Menke-Pluymers M: Nonsentinel lymph-node involvement in patients with breast cancer and sentinel node metastasis; too early to abandon axillary clearance. J Clin Pathol, 2002; 55:932-35.
44. Leidenius MMH, Vironen JH, Riihela MS, Krogerus LA, Toivonen TS, von Smitten KA, Heikkila PS: The prevalence of nonsentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol, 2005; 31:13-18.
45. Schrenk P, Konstantiniuk P, Wolfl S: Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg, 2005; 92:707-13.
46. Liang WC, Sickle-Santanello BJ, Nims TA: Is a complete axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg, 2001; 182:365-68.
47. Fournier K, Schiller A, Perry RR, Laronga C: Micrometastasis in the sentinel lymph node of breast cancer does not mandate completing axillary dissection. Ann Surg, 2004; 239:859-65.
48. Weiser MR, Montgomery LL, Susnick B, Tan LK, Borgen PI, Cody HS: Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwile? Ann Surg Oncol, 2000; 7:651-5.
49. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet, 1997; 349:1864-867.
50. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D: Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst, 1999; 91:368-73.
51. Chao C, Wong SL, Ackermann D, Simpson D, Carter MB, Brown CM, Edwards MM, McMasters KM: Utility of intraoperative frozen section analysis of sentinel lymph node in breast cancer. Am J Surg, 2001; 182:609-15.
52. Schulze T, Mucke J, Markwardt J, et al: Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol, 2006;93:109-19.
53. Langer I, Guller U, Berclaz G, et al: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multi center study on 659 patients. Ann Surg, 2007; 245:452-61.
54. Leidenius M, Leivonen M, Vironen J, et al: The conseguences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol, 2005; 92:23-31.